Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00550368 · ClinicalTrials.gov registry record · NA

Clinical Experiment of Helicobacter Pylori Transmission

A NA study of Infection and Achlorhydria, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT00550368 is a NA study of Infection and Achlorhydria that has completed, run by Stanford University. The registered enrollment target is 45 participants, below the 725-participant average among 41 other Infection trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00550368, a NA study of Infection and Achlorhydria, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The study proposes to test whether chronic infection with Helicobacter pylori protects individuals from symptomatic infection with enteropathogenic E. coli. The study will also evaluate the effect of gastric acidity in this relationship.

Conditions Studied

Interventions

  • BIOLOGICAL Biological intervention: Enteropathogenic E. coli

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2005-08
Est. Completion 2009-04
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT00550368

The ClinicalTrials.gov registry entry for NCT00550368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 725-participant average among 41 other Infection trials with a reported enrollment target (94% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Infection appearing as the primary indexed condition, and to 1 intervention - of which Biological intervention: Enteropathogenic E. coli is the first listed.

NCT00550368 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00550368 about?

NCT00550368 is a clinical study titled "Clinical Experiment of Helicobacter Pylori Transmission". The study proposes to test whether chronic infection with Helicobacter pylori protects individuals from symptomatic infection with enteropathogenic E. coli. The study will also evaluate the effect of gastric acidity in this relationship.

What is the current status of trial NCT00550368?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2005-08. Estimated completion is 2009-04.

What conditions does trial NCT00550368 study?

This clinical trial studies the following conditions: Infection, Achlorhydria.

What interventions are being tested in trial NCT00550368?

The interventions under investigation include: Biological intervention: Enteropathogenic E. coli (BIOLOGICAL).

Who is sponsoring clinical trial NCT00550368?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00550368 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.